Cann Group Limited
| Primary URL | Location | Industry | cann[.]com[.]au |
Country
Australia
|
Agriculture
|
|---|
Profile
Cann Group Limited is an Australian company that focuses on the cultivation, production, and supply of medicinal cannabis products. The firm holds a license to grow cannabis for medical use under the Australian Office of Drug Control. Its core activities include developing standardized cannabis extracts and formulations intended for therapeutic applications. Cann Group serves patients and healthcare providers primarily within the Australian medical cannabis market, while also exploring opportunities for international distribution. The company’s operations are centered on ensuring product quality, consistency, and compliance with stringent regulatory standards.
Cann Group distinguishes itself through its specialization in the medicinal cannabis sector, emphasizing research-driven cultivation techniques and rigorous quality‑control processes. The company positions itself as a licensed producer that can supply both domestic and potentially export‑grade medical cannabis products. Its notable competencies include expertise in horticultural practices specific to cannabis, extraction technology, and formulation development for therapeutic use. Structurally, Cann Group Limited is a publicly listed entity on the Australian Securities Exchange, trading under the ticker CAN. The firm’s ownership is therefore dispersed among public shareholders, with no single parent company disclosed in the available sources. In early 2021 the company experienced a cyber‑fraud incident that resulted in an unauthorized $3.6 million payment, prompting immediate IT security upgrades and cooperation with financial institutions and law‑enforcement agencies. Despite the financial strain highlighted by quarterly operating cash outflows, Cann Group retained substantial cash reserves following the event.